Editor-in-Chief

Associate Editors

National Institute of Cholera and Enteric Diseases; Kolkata, India

David Geffen School of Medicine, UCLA; Los Angeles, CA, USA

CSL Limited; Parkville, Victoria, Australia

International Vaccine Institute; Seoul, South Korea

University of Chicago; Chicago, IL, USA

Coley Pharmaceutical Group; Kanata, Ontario, Canada

Novartis Vaccines and Diagnostics; Siena, Italy

University of Maryland School of Medicine; Baltimore, MD, USA

Communicable Disease Surveillance Centre; London, UK

National Institute for Biological Standards and Control; Potters Bar, UK

GlaxoSmithKline Biologicals; Rixensart, Belgium

IOMAI Corporation; Gaithersburg, MD, USA

Berna Biotech; Berne, Switzerland

Queensland Institute of Medical Research; Queensland, Australia

Oakland Research Institute; Oakland, CA, USA

London School of Hygiene and Tropical Medicine; London, UK

GBF-National Research Centre for Biotechnology; Braunschweig, Germany

Intracel; Frederick, MD, USA

Walter and Eliza Hall Institute of Medical Research; Parkville, Victoria, Australia

Transgene; Lyon, France

Center for Innovations in Medicine, Biodesign Institute; Tempe, AZ, USA

Consultant

Merck Research Laboratories, West Point, PA, USA

National Public Health Institute; Helsinki, Finland

Avant ImmunoTherapeutics; Needham, MA, USA

Emory University; Atlanta, GA, USA

International AIDS Vaccine Institute; New York, NY, USA

BN ImmunoTherapeutics; Mountain View, CA, USA

Johns Hopkins School of Public Health; Baltimore, MD, USA

Memorial Sloan-Kettering Cancer Center; New York, NY, USA

Univeristy of Göteborg; Göteborg, Sweden

University of Kansas; Lawrence, KS, USA

University at Buffalo, SUNY; Buffalo, NY, USA

Baylor College of Medicine; Houston, TX, USA

Pharmexa-Epimmune, Inc.; San Diego, CA, USA

Harvard Medical School; Boston, MA, USA

Cepheid; Sunnyvale, CA, USA

University of Rochester Medical Center; Rochester, NY, USA

Harvard Medical School; Boston, MA, USA

University at Buffalo, SUNY; Buffalo, NY, USA

Center for Immunotherapy, University of Connecticut; Farmington, CT, USA

Sanofi Pasteur; Toronto, ON, Canada

Novartis Vaccines; Emeryville, CA, USA

La Jolla Institute for Allergy and Immunology; San Diego, CA, USA

McGill University; Montreal, QC, Canada

Acambis PLC; Cambridge, MA, USA

University of Pennsylvania; Philadelphia, PA, USA

Centers for Disease Control and Prevention; Atlanta, GA, USA

Editorial Board

Idera Pharmaceuticals, Inc.; Cambridge, MA, USA

Atobis S.A.; Brussels, Belgium

Weizmann Institute of Science; Rehovot, Israel

Kaiser-Permanente; Oakland, CA, USA

Health Protection Agency; London, UK

Centers for Disease Control and Prevention; Atlanta, GA, USA

Ben-Gurion University; Beer-Sheva, Israel

St. George's Hospital Medical School; London, UK

Consultant; Niantic, CT, USA

Vanderbilt University; Nashville, TN, USA

Bill & Melinda Gates Foundation; Seattle, WA, USA

University of Queensland; Queensland, Australia

Consultant

Crucell; Amsterdam, The Netherlands

Food and Drug Administration; Rockville, MD, USA

University of Melbourne; Parkville, Victoria, Australia

Dalhousie University; Halifax, NS, Canada

Harborview Medical Center; Seattle, WA, USA

University of Maryland School of Medicine; Baltimore, MD, USA

Nobel Foundation; Stockholm, Sweden

National Institute of Biological Standards and Control; Hertfordshire, UK

Kleiner Perkins Caufield & Byers; Harvard, MA, USA

The Children's Hospital of Philadelphia; Philadelphia, PA, USA

Sanofi Pasteur; Doylestown, PA, USA

Bill & Melinda Gates Foundation; Seattle, WA, USA

Albert B. Sabin Vaccine Institute; Potomac, MD, USA

UK Department of Health; London, UK

Harvard Medical School; Boston, MA, USA